SCHEMBL6081390

SCHEMBL6081390

Brc1c[nH]c2ccc(OCc3ccccc3)cc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.64
KDM4E B2RXH2 1/20 0.64
MAPT P10636 1/20 0.64
LTA4H P09960 4/20 0.62
PLA2G2A P14555 4/20 0.62
HTR1D P28221 5/20 0.60
SLC6A4 P31645 1/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
POLB P06746 1/20 0.56
HSP90AA1 P07900 1/20 0.56
HSP90AB1 P08238 1/20 0.56
IMPDH2 P12268 1/20 0.54
HTR1A P08908 2/20 0.53
HTR1B P28222 2/20 0.53
GAA P10253 1/20 0.52
GPR55 Q9Y2T6 1/20 0.52
MAOB P27338 2/20 0.51
MAOA P21397 1/20 0.51
ALDH1A1 P00352 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29814579 0.88 IMPDH2 (0.65) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL23089216 0.88 IMPDH2 (0.65) TRPM8KDM4EMAPTLTA4HPLA2G2A
Tert-Butyl Formate SCHEMBL28092121 0.87 HTR1D (0.51) TRPM8KDM4EMAPTLTA4HPLA2G2A
Ethoxycarbonyl Group SCHEMBL27581538 0.87 HTR1D (0.52) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL29055668 0.86 HTR1D (0.54) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL29007183 0.82 TRPM8 (0.76) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL29617411 0.82 TRPM8 (0.76) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL2004881 0.82 TRPM8 (0.64) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL28506218 0.82 TRPM8 (0.64) TRPM8KDM4EMAPTLTA4HPLA2G2A
SCHEMBL8654866 0.82 TRPM8 (0.60) TRPM8KDM4EMAPTLTA4HPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed
US-20060004428-A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2006-01-05 US disclosed
CN-1705667-A New fused pyrrolo-carbazole or pyrido-pyrrolo-indole derivatives (i), useful for treating cancer SERVIER LAB (FR) 2005-12-07 CN disclosed
EP-1554277-A1 PYRROLO (3,4-C) CARBAZOLE AND PYRIDO (2,3-B) PYRROLO (3,4-E) INDOLE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2005-07-20 EP disclosed
WO-2004035582-A1 PYRROLO (3,4-C) CARBAZOLE AND PYRIDO (2,3-B) PYRROLO (3,4-E) INDOLE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2004-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP TRPM8 4519/4885KDM4E 4463/4885MAPT 1129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.